These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6072623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Physiology and pharmacology of belladonna therapy in acid-peptic disease.
    Sodeman WA, Augur NA, Pollard HM.
    Med Clin North Am; 1969 Nov; 53(6):1379-88. PubMed ID: 4900719
    [No Abstract] [Full Text] [Related]

  • 3. Studies on peptic ulcer disease with special reference to the effect of l-hyoscyamine.
    Walan A.
    Acta Med Scand Suppl; 1970 Nov; 516():1-57. PubMed ID: 5293126
    [No Abstract] [Full Text] [Related]

  • 4. [Evaluation of the inhibiting activity of a new parasympatholytic, Ketoscilium, on gastric secretion in humans].
    Lodola E.
    Minerva Gastroenterol; 1970 Nov; 16(2):99-103. PubMed ID: 5477403
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Antacid effect of a magnesium trisilicate-1-hyoscyamine combination preparation (Neoplex B)--clinical and function analytical studies].
    Piaty R.
    Wien Med Wochenschr; 1968 Feb 24; 118(8):157-9. PubMed ID: 4301560
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gastric secretory patterns before and during treatment with 1-hyoscyamine.
    Christiansen PM, Rodbro P.
    Scand J Gastroenterol; 1967 Feb 24; 2(4):251-6. PubMed ID: 4865175
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of peptic ulcer.
    Siurala M, Salmi H, Jussila J, Reissell P, Perttala Y, Haavisto J.
    Med Chir Dig; 1973 Feb 24; 2(3):139-43. PubMed ID: 4595016
    [No Abstract] [Full Text] [Related]

  • 12. A successful management of the peptic ulcer patient in industry.
    Paullus GE.
    Ind Med Surg; 1966 Jan 24; 35(1):21-3. PubMed ID: 4378322
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of 1-hyoscyamine on gastric secretion of acid and intrinsic factor in man.
    Dotevall G, Walan A, Weinfeld A.
    Gut; 1967 Jun 24; 8(3):276-80. PubMed ID: 6026500
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vivo and in vitro evaluation of liquid antacids.
    Fordtran JS, Morawski SG, Richardson CT.
    N Engl J Med; 1973 May 03; 288(18):923-8. PubMed ID: 4693244
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [New therapeutic developments in gastroenterology].
    Lebreton JM.
    Maroc Med; 1975 Jun 03; 55(591):335-7. PubMed ID: 1177517
    [No Abstract] [Full Text] [Related]

  • 20. [Changes of intragastric pH in patients with duodenal ulcer under the influence of: I. Antacids and milk derivatives taken after fasting. II. Antacids taken after an ordinary meal].
    de Paula Castro L, Resende HP.
    AMB Rev Assoc Med Bras; 1969 Apr 03; 15(4):157-64. PubMed ID: 5311441
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.